GlassScriptPhysician profile
Matthew David Jenkins
NPI 1427543644
$6,780.76
in general payments reported to CMS, 2019-2025
15 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $564 · 2021: $219 · 2022: $1,200 · 2023: $155 · 2024: $1,579 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.71 |
| Travel and Lodging | $1,066.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,434.97 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sioux Surgical INC | $1,266.99 | 2024-2025 | |
| Steelhead Surgical INC | $1,200.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $751.02 | 2019 | |
| Stryker Corporation | $729.09 | 2019-2021 | |
| Arthrex, INC. | $535.30 | 2024 | |
| Medical Device Business Services, INC. | $314.98 | 2019 | |
| Treace Medical Concepts, INC. | $121.72 | 2025 | |
| Organogenesis INC. | $115.06 | 2020-2024 | Puraply, Novachor |
| Smith+Nephew, INC. | $114.35 | 2021 | |
| Averitas Pharma INC. | $56.42 | 2023 | Qutenza |
| Paragon 28, INC. | $49.54 | 2019 | |
| Wright Medical Technology, INC. | $39.99 | 2020 | |
| Medline Industries LP | $35.80 | 2025 | |
| Mimedx Group, INC. | $15.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.